[
    [
        {
            "time": "",
            "original_text": "【基金必读】华夏嘉实中金等基金经理离任 大摩华鑫新基金延长募集期",
            "features": {
                "keywords": [
                    "基金经理",
                    "离任",
                    "大摩华鑫",
                    "新基金",
                    "延长募集期"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【基金必读】华夏嘉实中金等基金经理离任 大摩华鑫新基金延长募集期",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "“公募一哥”张坤“出手”天坛生物定增，最近半年三次参与定向增发",
            "features": {
                "keywords": [
                    "公募一哥",
                    "张坤",
                    "天坛生物",
                    "定增",
                    "定向增发"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "“公募一哥”张坤“出手”天坛生物定增，最近半年三次参与定向增发",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "“公募一哥”近半年3次出手，这一把浮盈近100%",
            "features": {
                "keywords": [
                    "公募一哥",
                    "浮盈",
                    "投资收益"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "“公募一哥”近半年3次出手，这一把浮盈近100%",
                "Correlation": 6,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【东北医药崔洁铭】天坛生物（600161）年报季报点评：新产能、新产品有序推进，业绩符合预期",
            "features": {
                "keywords": [
                    "天坛生物",
                    "新产能",
                    "新产品",
                    "业绩",
                    "预期"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【东北医药崔洁铭】天坛生物（600161）年报季报点评：新产能、新产品有序推进，业绩符合预期",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "这类投资火了！“公募一哥”近半年3次出手，这一把浮盈近100%！",
            "features": {
                "keywords": [
                    "投资",
                    "公募一哥",
                    "浮盈",
                    "投资热度"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "这类投资火了！“公募一哥”近半年3次出手，这一把浮盈近100%！",
                "Correlation": 6,
                "Sentiment": 9,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 7
            }
        }
    ]
]